Clinical Ref: For postmenopausal patients, the measurement of endometrial thickness is most accurate when taken in the midline sagittal plane, excluding any small pockets of fluid.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Clinical Uses
Triage and risk stratification for postmenopausal bleeding (PMB)
Determining the necessity for invasive endometrial sampling (biopsy or hysteroscopy)
Evaluating asymptomatic thickened endometrium found incidentally on imaging
When NOT to Use
Absolute thickness is a poor standalone screening tool for asymptomatic postmenopausal women. Routine screening for endometrial cancer using ultrasound is explicitly NOT recommended by ACOG or SGO in the absence of bleeding.
Section 2
Formula & Logic
Measurement Technique
Measured via Transvaginal Ultrasound (TVUS) in the mid-sagittal plane
Represents the maximum anteroposterior dimension of the endometrial echo (double-layer thickness)
Caliper placement: from the echogenic interface at the myometrium-endometrium junction to the contralateral interface
If intracavitary fluid is present, measure both single layers separately and sum them (do NOT include the fluid in the measurement)
Standard Thresholds (Postmenopausal)
≤ 4 mm (with PMB)
Endometrial cancer highly unlikely (NPV > 99%)
> 4 mm (with PMB)
Abnormal; requires tissue sampling
Asymptomatic
Threshold debated; frequently biopsied if > 11 mm
Section 3
Pearls/Pitfalls
Clinical Pearls
A 4 mm cutoff is extremely reliable for ruling out cancer, but it has low specificity (many false positives from polyps or hyperplasia).
An unmeasurble endometrium, or one with heterogeneous echotexture regardless of thickness, requires biopsy in a patient with PMB.
Common Pitfalls
In premenopausal women, thickness varies radically based on the menstrual cycle phase (can be up to 16 mm in secretory phase); fixed cutoffs do NOT apply.
Tamoxifen use classically causes subendometrial cystic changes that mimic thickening; TVUS often overestimates true endometrial thickness in these patients.
Do not interpret a "normal" thickness as reassuring if the patient has persistent or recurrent bleeding; biopsy is still warranted.
Section 4
Next Steps
Management in Postmenopausal Bleeding
01
Evaluate TVUS results: Thickness ≤ 4 mm.
02
If bleeding has stopped: Observation is appropriate. No biopsy required.
03
If bleeding is recurrent or persistent: Proceed to hysteroscopy or sonohysterography despite a normal thickness.
04
If thickness > 4 mm: Perform in-office pipelle endometrial biopsy.
05
If biopsy yields insufficient tissue AND bleeding persists: Proceed to hysteroscopy with D&C.
Section 5
Evidence Appraisal
ACOG Guidelines
The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.
ACOG Committee Opinion No. 734. • Obstet Gynecol.. 2018;Reaffirmed guideline solidifying the ≤ 4 mm cutoff for deferring biopsy in first-episode postmenopausal bleeding.
Endometrial thickness to exclude endometrial cancer in women with postmenopausal bleeding.
Smith-Bindman R et al. • JAMA.. 1998;Foundational meta-analysis: 96% sensitivity and >99% NPV for cancer at a ≤5 mm threshold (subsequently narrowed to ≤4 mm in modern practice).
Section 6
Literature
Historical Context
The shift from universal D&C for all postmenopausal bleeding to a non-invasive initial triage approach accelerated in the late 1990s as high-resolution transvaginal probes became widely available, driven strongly by the landmark 1998 JAMA meta-analysis.
